RxDoctor Payments Data

Lana Williams, MD

Psychiatry · Fresno, CANPI 1063698884

Payments from drug & device makers

$3,909in general payments, 2019–2025

Across 351 payments — averaging $11.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$921
  • Takeda Pharmaceuticals U.S.A., Inc.$625
  • AbbVie$434
  • Axsome Therapeutics, Inc.$419
  • Otsuka America Pharmaceutical, Inc.$355
  • Lundbeck LLC$328
  • plus $826 from 10 others

What the payments were for

  • Food & beverage$3,900100%
  • Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,909 in reported general payments places this provider in the 85th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$23,601
Medicare patients
42
Services billed
203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide13$6,396
Bupropion XlBupropion Hcl60$1,205
Quetiapine Fumarate13$711
Clonazepam33$436
Lamotrigine18$422
Aripiprazole19$362
Alprazolam15$200
Fluoxetine Hcl27$194
Temazepam12$158
Buspirone Hcl26$113
Trazodone Hcl32$101
Paroxetine Hcl14$79
Lorazepam22$76
Risperidone20$55

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$625$6,39613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Fresno

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →